You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HSP

Showing 1 - 25 of 447
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hereditary Spastic Paraplegia Trial (Shockwave Therapy)

Not yet recruiting
  • Hereditary Spastic Paraplegia
  • Shockwave Therapy
  • (no location specified)
Nov 7, 2022

Solid Tumor Trial in Durham (HS-196)

Suspended
  • Solid Tumor
  • Durham, North Carolina
    Duke University Medical Center
Dec 19, 2022

Hidradenitis Suppurativa Trial in Aarhus (RGRN-305, Placebo)

Completed
  • Hidradenitis Suppurativa
  • Aarhus, Denmark
    Aarhus University Hospital
Jan 30, 2023

Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

Terminated
  • Recurrent Melanoma
  • +3 more
  • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
  • Laboratory Biomarker Analysis
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Hereditary Spastic Paraparesis Trial in Bosisio Parini (SNAP questionnaire)

Completed
  • Hereditary Spastic Paraparesis
  • SNAP questionnaire
  • Bosisio Parini, Italy
    Eleonora Diella
Nov 24, 2021

Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor

Completed
Has Results
  • Metastatic or Unresectable Solid Tumor Malignancy
  • Fort Myers, Florida
  • +2 more
Feb 15, 2022

Hereditary Spastic Paraplegia, SPG47, SPG50 Trial in Boston

Recruiting
  • Hereditary Spastic Paraplegia
  • +10 more
    • Boston, Massachusetts
      Boston Children's Hospital
    Jul 8, 2022

    Melanoma Stage IV, Sarcoma, Squamous Cell Carcinoma Trial in Berlin (CTC isolation by HSP70)

    Recruiting
    • Melanoma Stage IV
    • +5 more
    • CTC isolation by HSP70
    • Berlin, Germany
      Klinik für Radioonkologie und Strahlentherapie
    May 12, 2021

    Melanoma Trial in Tampa (XL888, Vemurafenib)

    Active, not recruiting
    • Melanoma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 18, 2022

    Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,

    Recruiting
    • Stage II Bladder Cancer AJCC v8
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2022

    HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis

    Completed
    • Peripheral Arterial Disease
    • non-intervention
    • Guangzhou, Guangdong, China
      Nanfang Hospital
    Mar 4, 2021

    Rheumatoid Arthritis Trial in Nijmegen, Utrecht (autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the

    Recruiting
    • Rheumatoid Arthritis
    • autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70
    • Nijmegen, Netherlands
    • +2 more
    Feb 22, 2022

    Advanced Solid Tumors Trial in Nagoya, Kashiwa (HSP990)

    Terminated
    • Advanced Solid Tumors
    • Nagoya, Aichi, Japan
    • +1 more
    Dec 6, 2020

    Hodgkin Lymphoma, Adult, T Cell Lymphoma Trial in Barcelona (HSP-CAR30)

    Recruiting
    • Hodgkin Lymphoma, Adult
    • T Cell Lymphoma
    • HSP-CAR30
    • Barcelona, Spain
      Hospital Santa Creu i Sant Pau
    Nov 30, 2020

    Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

    Recruiting
    • Aplastic Anemia
    • +3 more
    • Anti-Thymocyte Globulin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 1, 2021

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • CDK Inhibitor AT7519
    • +3 more
    • Washington, District of Columbia
    • +5 more
    Oct 18, 2022

    Advanced Solid Malignancies Trial in Toronto, Toulouse Cedex 3, Barcelona (HSP990)

    Completed
    • Advanced Solid Malignancies
    • Toronto, Ontario, Canada
    • +2 more
    Dec 6, 2020

    Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,

    Active, not recruiting
    • Colorectal Adenocarcinoma
    • +14 more
    • Atlanta, Georgia
    • +2 more
    Jul 5, 2022

    Studying Non-motor Symptoms in HSP

    Completed
    • SPG4
    • EuroQol five dimensions questionaire (EQ-5D)
    • +4 more
    • Tübingen, Germany
      University Hospital Tübingen, Center for Neurology
    Aug 25, 2020

    Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2022

    Reduced Ventilator-Free Days and Bacterial Colonization of

    Withdrawn
    • Pneumonia
      • Chattanooga, Tennessee
        Erlanger Hospital
      Nov 23, 2020

      Paroxysmal Atrial Fibrillation Trial in Worldwide (TactiFlex SE, TactiFlex SE - HSP)

      Active, not recruiting
      • Paroxysmal Atrial Fibrillation
      • TactiFlex SE
      • TactiFlex SE - HSP
      • Birmingham, Alabama
      • +44 more
      Jul 8, 2022

      Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IV NSCLC Trial in Los Angeles (Hsp90 inhibitor AUY922, pemetrexed disodium,

      Completed
      • Recurrent Non-small Cell Lung Cancer
      • +2 more
      • Hsp90 inhibitor AUY922
      • +3 more
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center
      Sep 1, 2020

      Stomach Tumors Esophageal Tumors Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein Trial in Worldwide

      Completed
      • Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein
      • Boston, Massachusetts
      • +8 more
      Dec 6, 2020

      Traitment of Acute Lymphoblastique Leukemia With

      Recruiting
      • Acute T Lymphoblastic Leukemia (T-ALL)
      • Acute B Lymphoblastic Leukemia (B-ALL)
      • injection of BEP 800
      • Control
      • Dijon, France
        Chu Dijon Bourgogne
      Jun 19, 2020